Physician & Payer Forum

Primary Market Research at a Multiclient Price

Physician & Payer Forum presents the viewpoints and prescribing habits of physicians and MCO pharmacy directors on the front lines of the healthcare industry. The service provides topical and provocative insights into issues critical to the success of pharmaceutical and managed care companies. Reports feature direct feedback from high-volume-prescribing primary care physicians and/or specialists, viewpoints from the managed care sector, and insight into the impact of events on specific markets.

Physician & Payer Forum reveals:

• Prescribing and referral patterns of high-volume-prescribing primary care physicians and specialists
• How and why prescribing patterns may change in light of a major event
• How reimbursement patterns may change in light of a major event
• How MCO PDs intend to use cost control to guide prescribing

Each report includes interviews with 140+ high-volume-prescribing primary care physicians and/or market-dependent specialists, and 15-25 MCO pharmacy directors. Expert analysis provides greater insight into the survey results.

Our most recent Physician & Payer Forum reports:

The Impact of Razadyne’s Genericization and the Launch of Biologic Disease-Modifying Drugs on the Alzheimer’s Disease Market

Avandia: One Year Later – A Physician and Payer Perspective

The Impact of Risperdal’s Patent Expiry on the Antipsychotic Market: Clinician and Payer Attitudes

Are Payers and Physicians Ready for a Paradigm Shift in Preventive Cardiology? An Assessment of Current and Future Use of HDL-Targeting Therapies

The Emergence of New Biologic Treatment Options for Crohn’s Disease and Ulcerative Colitis: Physician and Payer Attitudes

Download our Physician & Payer Forum brochure

View 2008 Physician & Payer Forum report titles